Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-21-006579
Filing Date
2021-05-14
Accepted
2021-05-14 16:16:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 11365
2 GRAPHIC g115570g0513204313099.jpg GRAPHIC 2495
3 GRAPHIC g115570g0513204313671.jpg GRAPHIC 1475
  Complete submission text file 0000950123-21-006579.txt   18086
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations